STI Clinical Update Webinar – Syphilis: A Case-Based Review and Update

March 28, 2024

9:30AM-11:00AM (MT)

Presented by Dr. Kelly Johnson

Please note: CME not available for viewing the webinar recording.

Learning Objectives:

List common causes for genital ulcerative disease
Interpret results of traditional & reverse syphilis screening algorithms
Explain the clinical significance of changes in non-treponemal titers
Name a resource for help interpreting different combinations of serologic results

Fact sheets for patients that answer basic questions about STIs.

Fact Sheets for Patients

STI Clinical Updates: Santa Barbara County

Registration closes on April 19, 2024

South County session: Santa Barbara, CA (in-person only)
Monday, April 22, 2024
11:00AM-1:00PM (PDT)
1.75 CME units at no cost

North County Session: Santa Maria, CA (in-person only)
Tuesday, April 23, 2024
11:00AM-1:00PM (PDT)
1.75 CME units at no cost

Presenter
Dr. Eric Tang, Chief, Medical & Scientific Affairs Section | Mpox Lead
STD Control Branch, California Department of Public Health

Learning Objectives

Summarize current STI trends in Santa Barbara County
Describe the stages of syphilis and the recommended treatment and follow-up for people with syphilis
Describe how to diagnose, manage and treat DGI

2024 STI Clinical Update: San Francisco Department of Public Health (SFDPH)

Thursday, March 14, 2024

Hybrid event. Please note: CME not available for viewing the recording.

Presented by:

Dr. Oliver Bacon
Medical Director, San Francisco City Clinic
San Francisco Department of Public Health

Dr. Franco Chevalier
Deputy Medical Director, San Francisco City Clinic
San Francisco Department of Public Health

Dr. Stephanie Cohen
Director, HIV/STI Prevention, Disease Control Branch,
San Francisco Department of Public Health

Dr. Kelly Johnson
Medical Director, California Prevention Training Center
Public Health Medical Officer, STD Control Branch, California Department of Public Health

Emcee: Dr. Ina Park
Principal Investigator, California Prevention Training Center

Description

More than 2.5 million cases of chlamydia, gonorrhea, and syphilis were reported in the U.S. in 2022, and San Francisco has higher chlamydia, gonorrhea, syphilis, and HIV rates compared to the rest of the state and nation. This half-day, hybrid event will provide important updates in the field of sexual health to help providers strengthen the delivery of STI prevention and care. Hear from local experts on STI epidemiology in San Francisco, updates on Doxy-PEP implementation, recognizing dermatologic manifestations of STIs, and a lively case panel.

Learning Objectives

Summarize current STI trends in San Francisco
Be familiar with updates to STI treatment guidelines and innovations in STI prevention and diagnostics
Understand how to implement Doxy-PEP for STI prevention
Recognize common dermatologic manifestations of STIs

STI Clinical Update Webinar – Introduction to Syphilis and Congenital Syphilis: A Phoenix IHS and CAPTC Event

January 11, 2024

8:30AM-12:00PM (MST)

Presented by CAPTC Clinical Faculty

Please note: CME not available for viewing the webinar recording.

Presenters:

Sharon Adler, MD, MPH, Clinical Faculty, California Prevention Training Center
Wyatt Hanft, MD, MPH, AAHIVS, STI Fellow, California Prevention Training Center
Tamara Ooms, RN, MSN, FNP, Program Manager, California Prevention Training Center
Ina Park, MD, MS, Principal Investigator, California Prevention Training Center
Rosalyn Plotzker, MD, MPH, Clinical Faculty, California Prevention Training Center
Moderator: Kelly Johnson, MD, MPH, Medical Director, California Prevention Training Center

Learning Objectives:

Describe the varied clinical manifestations of syphilis in adults & congenital syphilis (CS) in infants

Recognize that there are two different screening algorithms used to diagnose syphilis in adults

Define adequate treatment for syphilis, including during pregnancy

List at least 3 strategies to prevent syphilis in adults and infants

STI Expert Hour Webinar – Navigating the Bicillin L-A Shortage: A Conversation with PharmD Dr. Kathy Yang

January 31, 2024

12:00PM-1:15PM (PST)

1.25 CME units at no cost

Please note: No CME available for viewing the webinar recording.

Learning Objectives

List at least 2 factors contributing to ongoing Bicillin L-A shortages
Describe a framework for prioritizing Bicillin L-A when supplies are limited
Name potential alternative treatments for syphilis in non-pregnant people
Develop a decision-making process for the treatment of syphilis when standard guidelines cannot be followed or when data is insufficient.

Meet Our Expert: Kathy Yang, PharmD, MPH

Dr. Yang is a Health Sciences Clinical Professor in the Department of Clinical Pharmacy and the Co-Vice Dean of Clinical Innovation and Entrepreneurship at the University of California, San Francisco School of Pharmacy. She is also an Infectious Diseases Clinical Pharmacist in the UCSF Medical Center. Dr. Yang specializes in pharmacokinetic and pharmacodynamic optimization of the treatment of multi-drug resistant infections, particularly gram-negative bacteria such as Pseudomonas aeruginosa. For the past 3 years, Dr. Yang has focused her efforts on the clinical management of COVID-19.

Congenital Syphilis Hotline Pilot

California Clinicians:

Do you have an URGENT congenital syphilis case and need SAME DAY expert consultation?

January 1 – March 31, 2024

www.stdccn.org

2023 Hawai’i STI Clinical Update

October 17, 2023

9AM-5PM (HST)

Honolulu, HI / Virtual

1-day in-person and virtual training covering the following topics:

Syphilis in Pregnancy
Congenital Syphilis
Gonorrhea (GC)/Chlamydia (CT), including extragenital testing
Doxycycline Post-exposure prophylaxis (doxy-PEP), Expedited Partner Therapy (EPT)
Dermatologic manifestations of STIs – Urethritis/Vaginitis (including syndromic management)
Sexual assault and STIs

Presented by:

Kelly Johnson, MD,MPH, Medical Director, California Prevention Training Center
Tamara Ooms, RN, MSN, FNP, Program Manager, California Prevention Training Center
Rosalyn Plotzker, MD, MPH, Clinical Faculty, California Prevention Training Center
Alan Katz, MD, MPH, Staff Physician, Hawai’i State Department of Health
Moderator: Breena Gaskov, BS, Outreach Epidemiological Specialist, Hawai’i State Department of Health

Learning Objectives

Explain prenatal syphilis screening and treatment recommendations
Describe the clinical and public health approaches to GC/CT prevention
Summarize data from recent studies exploring the use of doxy PEP to prevent bacterial STIs
Compare potential strategies for doxy-PEP implementation in clinical settings
Recognize dermatologic signs of sexually transmitted infections (STIs)
Delineate treatment approaches for syndromes suggestive of STIs

STI Clinical Update Humboldt County-Addressing the Rise of Syphilis: A Review of Clinical Management of Syphilis and Congenital Syphilis for Health Care Providers

Presented by Drs. Kathleen Jacobson and Wyatt Hanft

December 5, 2023

Learning Objectives:

Apply California’s expanded syphilis screening recommendations
Describe the stages of syphilis and the recommended treatment and follow up for people with syphilis
Compare the traditional and reverse algorithm for syphilis screening

Please note: CME not offered for viewing the recording of the update

How to Prescribe Expedited Partner Therapy (EPT) for Sexually Transmitted Infections

Expedited Partner Therapy (EPT) is the clinical practice of treating sex partners of patients diagnosed with certain sexually transmitted infections (STIs) – including chlamydia (CT), gonorrhea (GC), and trichomoniasis – without the health care provider first examining the partner(s). EPT usually involves patient delivered partner therapy (PDPT), in which the patient delivers the medication or a prescription to their partner(s). While evaluating the partner and providing other needed health services would be ideal, this is often not feasible. EPT can be provided confidentially; it is effective, safe, acceptable to patients and partners, and helps to ensure timely partner treatment.

This resource contains information on how to prescribe EPT in California, including sample prescriptions, information on billing/reimbursement, and patient-facing materials.

For more information on EPT and why it should be prescribed, see “Expedited Partner Therapy (EPT) for Sexually Transmitted Infections: A Resource for California Health Care Providers – What is EPT and Why Should I Prescribe It?”

View PDF